{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:46:03Z","timestamp":1792608363874,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"German Federal Ministry of Education and Research","award":["01KX2021"],"award-info":[{"award-number":["01KX2021"]}]},{"name":"German Federal Ministry of Education and Research","award":["01KX2121"],"award-info":[{"award-number":["01KX2121"]}]},{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fair allocation of funding in multi-centre clinical studies is challenging. Models commonly used in Germany\u00a0-\u00a0the case fees (\u201cfixed-rate model\u201d, FRM) and up-front staffing and consumables (\u201cup-front allocation model\u201d, UFAM) lack transparency and fail to suitably accommodate variations in centre performance. We developed a performance-based reimbursement model (PBRM) with automated calculation of conducted activities and applied it to the cohorts of the National Pandemic Cohort Network (NAPKON) within the Network of University Medicine (NUM). The study protocol activities, which were derived from data management systems, underwent validation through standardized quality checks by multiple stakeholders. The PBRM output (first funding period) was compared among centres and cohorts, and the cost-efficiency of the models was evaluated. Cases per centre varied from one to 164. The mean case reimbursement differed among the cohorts (1173.21\u20ac [95% CI 645.68\u20131700.73] to 3863.43\u20ac [95% CI 1468.89\u20136257.96]) and centres and mostly fell short of the expected amount. Model comparisons revealed higher cost-efficiency of the PBRM compared to FRM and UFAM, especially for low recruitment outliers. In conclusion, we have developed a reimbursement model that is transparent, accurate, and flexible. In multi-centre collaborations where heterogeneity between centres is expected, a PBRM could be used as a model to address performance discrepancies.<\/jats:p><jats:p>Trial registration: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04768998\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04768998<\/jats:ext-link>; <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04747366\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04747366<\/jats:ext-link>; <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04679584\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04679584<\/jats:ext-link>.<\/jats:p>","DOI":"10.1038\/s41598-024-63945-5","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T05:02:02Z","timestamp":1718254922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A precise performance-based reimbursement model for the multi-centre NAPKON cohorts \u2013 development and evaluation"],"prefix":"10.1038","volume":"14","author":[{"given":"Katharina S.","family":"Appel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin Huang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana M.","family":"Nunes de Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Peter","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bahmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Ballhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Balzuweit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Bellinghausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Blumentritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Brechtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Chaplinskaya-Sobol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Erber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsia","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Heyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Illig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Kohls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Kollek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Krist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Lorbeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Miljukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazar","family":"Mitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"N\u00fcrnberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Pley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Schattschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Christian","family":"Stubbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thalea","family":"Tamminga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes Josef","family":"Tebbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J. G. T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Wiedmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg Janne","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"63945_CR1","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.ijproman.2015.02.001","volume":"33","author":"J vom Brocke","year":"2015","unstructured":"vom Brocke, J. & Lippe, S. Managing collaborative research projects: A synthesis of project management literature and directives for future research. Int. J. Proj. Manag. 33, 1022\u20131039 (2015).","journal-title":"Int. J. Proj. Manag."},{"key":"63945_CR2","doi-asserted-by":"crossref","unstructured":"Katsouyanni, K. Collaborative research: Accomplishments & potential. Environ. Health 7 (2008).","DOI":"10.1186\/1476-069X-7-3"},{"key":"63945_CR3","doi-asserted-by":"crossref","unstructured":"de Paoli, P. Institutional shared resources and translational cancer research. J. Transl. Med. 7 (2009).","DOI":"10.1186\/1479-5876-7-54"},{"key":"63945_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/jep.12100","volume":"20","author":"SR Rosas","year":"2014","unstructured":"Rosas, S. R. et al. Assessing the challenges of multi-scope clinical research sites: An example from NIH HIV\/AIDS clinical trials networks. J. Eval. Clin. Pract. 20, 149\u2013157 (2014).","journal-title":"J. Eval. Clin. Pract."},{"key":"63945_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1328","volume":"369","author":"L Wynants","year":"2020","unstructured":"Wynants, L. et al. Prediction models for diagnosis and prognosis of covid-19: Systematic review and critical appraisal. BMJ 369, m1328 (2020).","journal-title":"BMJ"},{"key":"63945_CR6","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1016\/j.jinf.2020.04.008","volume":"81","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Risk factors associated with disease severity and length of hospital stay in COVID-19 patients. J. Infect. 81, e95\u2013e97 (2020).","journal-title":"J. Infect."},{"key":"63945_CR7","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s12913-022-07847-0","volume":"22","author":"J Dol","year":"2022","unstructured":"Dol, J. et al. Health system impacts of SARS-CoV - 2 variants of concern: A rapid review. BMC Health Serv. Res. 22, 544 (2022).","journal-title":"BMC Health Serv. Res."},{"key":"63945_CR8","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10654-022-00896-z","volume":"37","author":"M Schons","year":"2022","unstructured":"Schons, M. et al. The German National Pandemic Cohort Network (NAPKON): Rationale, study design and baseline characteristics. Eur. J. Epidemiol. 37, 849\u2013870 (2022).","journal-title":"Eur. J. Epidemiol."},{"key":"63945_CR9","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.healthpol.2015.05.003","volume":"119","author":"PE Baxter","year":"2015","unstructured":"Baxter, P. E. et al. Leaders\u2019 experiences and perceptions implementing activity-based funding and pay-for-performance hospital funding models: A systematic review. Health policy 119, 1096\u20131110 (2015).","journal-title":"Health policy"},{"key":"63945_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/heapol\/czp002","volume":"24","author":"C Eldridge","year":"2009","unstructured":"Eldridge, C. & Palmer, N. Performance-based payment: Some reflections on the discourse, evidence and unanswered questions. Health Policy Plan. 24, 160\u2013166 (2009).","journal-title":"Health Policy Plan."},{"key":"63945_CR11","volume":"9","author":"KS Palmer","year":"2015","unstructured":"Palmer, K. S. et al. Activity-based funding of hospitals and its impact on mortality, readmission, discharge destination, severity of illness, and volume of care: A systematic review and meta-analysis. PLoS One 9, e0121163 (2015).","journal-title":"PLoS One"},{"key":"63945_CR12","first-page":"674","volume":"294","author":"H-U Prokosch","year":"2022","unstructured":"Prokosch, H.-U. et al. The COVID-19 data exchange platform of the German university medicine. Stud. Health Technol. Inform. 294, 674\u2013678 (2022).","journal-title":"Stud. Health Technol. Inform."},{"key":"63945_CR13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.healthpol.2018.04.007","volume":"122","author":"V Burau","year":"2018","unstructured":"Burau, V., Dahl, H. M., Jensen, L. G. & Lou, S. Beyond activity based funding. An experiment in Denmark. Health policy (Amsterdam, Netherlands) 122, 714\u2013721 (2018).","journal-title":"Health policy (Amsterdam, Netherlands)"},{"key":"63945_CR14","first-page":"165","volume":"32","author":"R Grimaldi","year":"2002","unstructured":"Grimaldi, R. & von Tunzelmann, N. Assessing collaborative, pre-competitive R&D projects: The case of the UK LINK scheme. R D Manag. 32, 165\u2013173 (2002).","journal-title":"R D Manag."},{"key":"63945_CR15","first-page":"51","volume":"38","author":"P Gist","year":"2007","unstructured":"Gist, P. & Langley, D. Application of standard project management tools to research\u2014A case study from a multi-national clinical trial. J. Res. Adm. 38, 51\u201358 (2007).","journal-title":"J. Res. Adm."},{"key":"63945_CR16","doi-asserted-by":"publisher","first-page":"e2381","DOI":"10.1002\/rmv.2381","volume":"32","author":"LB Shrestha","year":"2022","unstructured":"Shrestha, L. B., Foster, C., Rawlinson, W., Tedla, N. & Bull, R. A. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission. Rev. Med. Virol. 32, e2381 (2022).","journal-title":"Rev. Med. Virol."},{"key":"63945_CR17","unstructured":"Clinical management of COVID-19: living guideline, 13 January 2023. Geneva: World Health Organization; 2023 (WHO\/2019-nCoV\/clinical\/2023.1). Licence: CC BY-NC-SA 3.0 IGO."},{"key":"63945_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/jncimonographs\/lgi034","volume":"35","author":"SM Greene","year":"2005","unstructured":"Greene, S. M., Hart, G. & Wagner, E. H. Measuring and improving performance in multicenter research consortia. J. Natl. Cancer Inst. Monogr. 35, 26\u201332 (2005).","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"63945_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s11192-018-2910-8","volume":"117","author":"A Zharova","year":"2018","unstructured":"Zharova, A., Tellinger-Rice, J. & H\u00e4rdle, W. K. How to measure the performance of a collaborative research center. Scientometrics 117, 1023\u20131040 (2018).","journal-title":"Scientometrics"},{"key":"63945_CR20","first-page":"1","volume":"2","author":"AAH Nasser","year":"2022","unstructured":"Nasser, A. A. H. et al. How to set up and run a multi-centre trainee-led collaborative project. J. Surg. Protoc. Res. Methodol. 2, 1\u20133 (2022).","journal-title":"J. Surg. Protoc. Res. Methodol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63945-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63945-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63945-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T05:02:36Z","timestamp":1718254956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-63945-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["63945"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-63945-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"assertion":[{"value":"28 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DM received speaker honoraria from Free University of Berlin and travel compensation from IQVIA. JPR received consulting fees and personal fees (written expertise on data linkage) from the German Ministry for Heath. JPR has grants from the German Ministry of Research and Education (BMBF): Network University Medicine (NUM), CArdiovascular diseases \u2013 Enhancing Healthcare through cross-sectoral Routine data integration (CAEHR), Advancing Cardiovascular Risk Identification with Structured Clinical Documentation and Biosignal Derived Phenotypes Synthesis (ACRIBIS), EVAluation research based on data from routine clinical care 4 the MII (EVAL4MII); Bavarian State (Ministry for Science and the Arts): Digital Oncology (DigiOnko); Federal Joint Committee (GBA) within the Innovationsfonds: Perioperative interdisciplinary, intersectoral process optimization (Peri-OP), Patient typology for needs-based and more effective coaching in patients with hormone receptor-positive breast cancer (Pa-Typ). JJV has personal fees from Merck\/MSD, Gilead, Pfizer, Astellas Pharma, Basilea, German Centre for Infection Research (DZIF), University Hospital Freiburg\/Congress and Communication, Academy for Infectious Medicine, University Manchester, German Society for Infectious Diseases (DGI), \u00c4rztekammer Nordrhein, University Hospital Aachen, Back Bay Strategies, German Society for Internal Medicine (DGIM), Shionogi, Molecular Health, Netzwerk Universit\u00e4tsmedizin (NUM), Janssen, NordForsk, Biontech, APOGEPHA. JJV has grants from Merck\/MSD, Gilead, Pfizer, Astellas Pharma, Basilea, German Centre for Infection Research (DZIF), German Federal Ministry of Education and Research (BMBF), Deutsches Zetrum f\u00fcr Luft- und Raumfahrt (DLR), University of Bristol, Rigshospitalet Copenhagen, Network University Medicine. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13607"}}